MOF Derived CoFe₂O₄@Carbon Nanofibers for Supercapacitor Application
ChemSci Advances · 2024
DOI: 10.69626/csa.2024.0034 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemSci Advances, 2024. Verfasst von T.P. Kamble und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
This study presents the synthesis and electrochemical evaluation of MOF-derived CoFe2O4 nanoparticles anchored on carbon nanofibers (CoFe2O4@CNFs) for supercapacitor applications. By integrating hydrothermal and electrospinning techniques, we successfully fabricated CoFe2O4@CNFs with enhanced supercapacitive properties. The electrochemical performance of CoFe2O4@CNFs was rigorously assessed, revealing a remarkable specific capacitance of 527 F/g at a current density of 1 A/g. Additionally, the electrode demonstrated a power density of 234.93 W/kg and an energy density of 16.58 Wh/kg. These results highlight the synergistic effect of combining MOF-derived bimetallic transition metal oxides with carbon nanofibers, underscoring their potential in advancing supercapacitor technology. The findings suggest that CoFe2O4@CNFs can serve as a promising candidate for high-performance energy storage applications, offering a viable pathway to enhance the efficiency and capacity of supercapacitors.
Zitieren
APA
Kamble, T., Shingte, S., Chavan, V., Kim, D., Chougale, A., Dongale, T., & Patil, P. (2024). MOF Derived CoFe₂O₄@Carbon Nanofibers for Supercapacitor Application. ChemSci Advances. https://doi.org/10.69626/csa.2024.0034
Vancouver
Kamble T, Shingte S, Chavan V, Kim D, Chougale A, Dongale T, et al. MOF Derived CoFe₂O₄@Carbon Nanofibers for Supercapacitor Application. ChemSci Advances. 2024. doi:10.69626/csa.2024.0034
BibTeX
@article{Kamble2024,
author = {Kamble, T.P. and Shingte, S.R. and Chavan, V.D. and Kim, Deok-Kee and Chougale, A.D. and Dongale, T.D. and Patil, P.B.},
title = {MOF Derived CoFe₂O₄@Carbon Nanofibers for Supercapacitor Application},
journal = {ChemSci Advances},
year = {2024},
doi = {10.69626/csa.2024.0034}
}
EUVIMED